The Marginal Bone Loss in Dental Implants (BL-Implants)

The Marginal Bone Loss in Implants of External Connection Versus Internal Connection and Submerged Implants Versus Non-submerged Implants

When an implant is placed, it is assumed that there will be a loss of bone in the more coronal area around it. The placement of the implant in relation to bone level, either crestal or subcrestal and the type of connection chosen, either external connection or internal connection, have been related as one of the factors that caused this loss. The preservation of the peri-implant bone influences the shape and contour of the underlying soft tissues, which are important for the aesthetic result of the treatment and for the success of the same.

Hypothesis: The hypothesis is that there are no differences between the external and internal connection with regard to marginal bone loss. In implants placed at the crestal and subcrestal level, the hypothesis is that there is greater marginal bone loss in implants placed at the subcrestal level.

Objectives: Main: To evaluate the marginal bone loss around implants of internal connection and external connection. Secondary: To compare the loss of bone in implants of internal connection placed at crestal and subcrestal level. To evaluate intra and post-operative complications.

Material and methods: A prospective and randomized radiological study will be performed. 150 implants will be placed in patients who must present partial edentulism and require the replacement of at least 2 crowns on implants in the same jaw. In a randomized manner, implants of external connection and internal connection will be placed. Other features such as surface treatment type of the implant will be similar in both types of implants to reduce bias.

With this study the investigators will try to define if there is a procedure in when to the connection of the implant and the location of this, that is more beneficial with respect to the preservation of bone.

Study Overview

• Status: Active, not recruiting
• Conditions: Dental Implants
• Intervention / Treatment: Device: External-Connection non-submerged Imp; Device: Internal Connection Submerged implants; Device: Internal Connection non-Submerged Impl

Detailed Description

Implant dentistry has undergone major development and expansion since the nineteen sixties, when Dr. Branemark (Sweden) introduced the concept of osseointegration. The use of implants to replace missing teeth and restore function has presented a high success rate and long-term survival. For this reason rehabilitation by means of implants has become standard and well accepted by patients, who increasingly demand treatments offering greater comfort and aesthetics. Implant-based treatments must fulfill a range of physiological, functional and aesthetic criteria before they can be considered successful. These include osseointegration stability and duration, absence of pathological processes, and aesthetics that satisfy the patient.

There are diverse types of implants and corresponding systems that connect the implant to the prosthesis. Implant connections fall into two main groups: External and Internal Connection.

When an implant is placed, it is estimated that there will be bone loss around this during the first year, both horizontally and vertically. Actually is considered successful if the loss of crestal bone around the implant is less than 1.5mm during the first year and less than 0.2 annually in the next. This bone loss continues to occur despite the new designs of implants that try to stop it. The preservation of the peri-implant bone is an important factor for the success of the same. The quantity and quality influence the shape and contour of the overlying soft tissues, which are important for the aesthetic result of the treatment. The hypothesis is that there are no differences between the external and internal connection with regard to marginal bone loss. In implants placed at the crestal and subcrestal level, the hypothesis is that more marginal bone is loss in implants placed at the subcrestal level design.

A prospective randomized controlled, split-mouth clinical trial with a sample size of 50 implants per arm is proposed.

Population of the study Patients attended in HOUB (Hospital Odontológico Universitario de Bellvitge. Master of Medicine Surgery and Implantology and Master of Dentistry in Oncology and Immunocompromised Patients).

Inclusion criteria Patients of general age who present partial edentulism in the mandible and / or maxilla and require the replacement of at least 2 teeth by implants in the same maxilla. The teeth must have been removed at least 4-6 months before implant placement. The minimum required bone height would be 6mm, which would be determined by an orthopantomography (1: 1) to be performed in all cases. The space where the implants are placed should have sufficient bone volume that does not require regeneration (height> 6mm and bone width> 5mm). If expansion is to be done, it should be done in both techniques. The minimum distance from one implant to the adjacent teeth should be at least 1.5 mm, and in the case of two or more adjacent implants, at least 3 mm between them.

Intervention 150 implants will be placed (50 of external connection and 100 of internal connection: 50 with design for infracrestal placement and crestal-level.) Following the inclusion criteria, patients should require the replacement of at least two teeth in the same jaw.

To randomize we will use the application created by a computer programmer that generates random numbers.

All implants will be placed by the students of 3rd of Master, using the same surgical protocol.

Post-operative monitoring and follow-up visits Once the implants are placed, a period of osseointegration of 4 months will be left in the maxilla and 3 in the mandible. The control visits to assess clinical aspects were performed by the principal investigator at the following times: (0) prior to implant placement, (1) implant placement, (2) at 7 (+/- 1) days of placing the implant, where it will be used to remove the suture, (3) within 15 days (+/- 2 days) of placing the implant, (4) one month after placement, (5) 3 months (+/- 2 weeks) if it is placed in the mandible and at 4 months (+/- 2 weeks) in the jaw, when the healing pillar will be placed, (6) one week later, ) (+/- 1 day) at the printing press, (8) at 7 (+/- 1 day), where a metal test would be performed and (9) in the following week (+/- 1 Day), in the placement of the prosthesis, (10) 6 months after placement of the prosthesis and (11) 12 months after placement of the prosthesis.

The X-ray control, to compare bone loss, would be performed by an independent evaluator at the following times: (T1) prior to implant placement, (T2) on the day of implant placement, (T3) per month, (T4) at the time of placement of the implant Prosthesis (without specifying in which month), (T5) at 6 months after loading and (T6) one year after occlusal loading.

The stability implants, would be performed by an independent evaluator using the analysis of the resonance frequency (Penguin device) The measurements will be made the day of implant placement, the day of placement of the healing abutment (two-three months after implant placement) and the day of delivery of the crown (3-4 months after placement of the implant)

Study variables - Primary study variables: Percentage of bone loss

- Secondary study variables: Tobacco consumption Plate Index (PLI) Bleeding index (SBI) Implant stability ratio (ISQ) Intra and postoperative parameters

Statistic analysis The data will be entered into an Excel database and processed using the statistical package (SPSS )Windows. The level of statistical significance will be p <0.05.

A descriptive study of all the variables and the relationship between bone loss and the implant system or the different variables will be analyzed by the t-student for the independent data or by non-parametric tests (Mann-W-U ) If the distribution is not normal.

The Chi-squared test will be used to analyze the qualitative variables. Multiple regression analysis will be used to evaluate the association between the dependent variable (bone loss at 0, 1, 4, 6 and 12 months) and the independent variables, internal connection or external connection. All the variables that could potentially affect the study relationship, such as age, sex, smoking, and oral hygiene, were used as control variables in the regression.

Blind study

Ethical aspects The study would be carried out in accordance with the general recommendations of the 1964 Declaration of Helsinki for biomedical research in humans.

Eligible patients would be explained in detail to the study protocol and given an information sheet to those who enroll, they would be given to sign two informed consents; The first, explaining the risk and complications derived from implant placement surgery and the second where they agree to participate in the study. All patients will have a medical history and a data collection sheet attached to their history

• Study Type: Interventional
• Enrollment (Anticipated): 20
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Barcelona, Spain, 08232
    • Natalia Palacios Garzon

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: ADULT; OLDER_ADULT; CHILD
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patients of general age who present partial edentulism in the mandible and / or maxilla and require the replacement of at least 2 teeth by implants in the same maxilla.
• The teeth must have been removed at least 4-6 months before implant placement.
• The minimum required bone height would be 6mm, which would be determined by an orthopantomography (1: 1)

Exclusion Criteria:

• History of use of bisphosphonates
• Evidence of serious systemic diseases such as recent infarction
• Uncontrolled diabetes, coagulation disorders, cancer, psychiatric contraindications,
• Active infection in the area of the implants
• Absence of an antagonist in the area of implant placement
• Pharmacological treatments capable of affecting gingival health
• Pregnant or lactating women.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: SINGLE

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: External-Connection non-submerged Imp; We will place implants with external connection and non- submerged to assess the bone loss around	Device: External-Connection non-submerged Imp; Through a surgical procedure, we will implant implant whit external connection and non submerged to patients.
EXPERIMENTAL: Internal Connection Submerged implants; We will place implants with internal connection and submerged to assess the bone loss around	Device: Internal Connection Submerged implants; Through a surgical procedure, we will implant implant whit internal connection and submerged to patients.
EXPERIMENTAL: Internal Connection non-Submerged Impl; We will place Internal connection implant and non-Submerged Implants to assess the bone loss around	Device: Internal Connection non-Submerged Impl; Through a surgical procedure, we will implant implant whit internal connection and non-submerged to patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
A COMPARISON BETWEEN THE DIFFERENT CONNECTIONS AND POSITIONING OF THE IMPLANTS REGARDING THE BONE OF LOSS	By means of measurements in millimeters in the radiographs, the loss of bone will be compared. These measurements will be made one month after the placement of the implant, at 3-4 months in the placement of the crown, 6 months after placement of the crown and one year after placement of the crown	1,4 years around

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
ANALYSIS OF THE RESONANCE FREQUENCY	Using the Penguin device, the investigators measure the coefficient of stability of the implant. Measurements will be made the day of implant placement, the day of placement of the healing abutment (two-three months after implant placement) and the day of delivery of the crown (3-4 months after placement Of the implant)	4-5months around

Collaborators and Investigators

• Sponsor: Hospital Universitari de Bellvitge
• Investigators: Principal Investigator: Natalia Palacios Garzón, PhD student, HUBellvitge Recruiting; Study Director: José López López, PhD, Hospital Universitari de Bellvitge

Publications and helpful links

General Publications

• Pozzi A, Tallarico M, Moy PK. Three-year post-loading results of a randomised, controlled, split-mouth trial comparing implants with different prosthetic interfaces and design in partially posterior edentulous mandibles. Eur J Oral Implantol. 2014 Spring;7(1):47-61.
• Penarrocha-Diago MA, Flichy-Fernandez AJ, Alonso-Gonzalez R, Penarrocha-Oltra D, Balaguer-Martinez J, Penarrocha-Diago M. Influence of implant neck design and implant-abutment connection type on peri-implant health. Radiological study. Clin Oral Implants Res. 2013 Nov;24(11):1192-200. doi: 10.1111/j.1600-0501.2012.02562.x. Epub 2012 Aug 28.
• Galindo-Moreno P, Fernandez-Jimenez A, O'Valle F, Monje A, Silvestre FJ, Juodzbalys G, Sanchez-Fernandez E, Catena A. Influence of the crown-implant connection on the preservation of peri-implant bone: a retrospective multifactorial analysis. Int J Oral Maxillofac Implants. 2015 Mar-Apr;30(2):384-90. doi: 10.11607/jomi.3804.

Study record dates

Study Major Dates

• Study Start (ACTUAL): May 8, 2017
• Primary Completion (ACTUAL): January 30, 2020
• Study Completion (ANTICIPATED): February 17, 2022

Study Registration Dates

• First Submitted: July 20, 2017
• First Submitted That Met QC Criteria: July 24, 2017
• First Posted (ACTUAL): July 28, 2017

Study Record Updates

• Last Update Posted (ACTUAL): September 13, 2021
• Last Update Submitted That Met QC Criteria: September 6, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Keywords: Bone loss, dental implant desing
• Other Study ID Numbers: HUB

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No